메뉴 건너뛰기




Volumn 3, Issue , 2009, Pages 43-52

Tiotropium bromide: An update

Author keywords

COPD; COPD exacerbations; COPD mortality; Lung function; Quality of life; Tiotropium bromide

Indexed keywords

FLUTICASONE PROPIONATE; FORMOTEROL; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL; SALMETEROL; TIOTROPIUM BROMIDE;

EID: 70350055703     PISSN: None     EISSN: 18743064     Source Type: Journal    
DOI: 10.2174/1874306400903010043     Document Type: Review
Times cited : (12)

References (67)
  • 1
    • 0027509977 scopus 로고
    • Muscarinic receptor subtypes in airways
    • Barnes PJ. Muscarinic receptor subtypes in airways. Life Sci. 1993; 52: 521-7.
    • (1993) Life Sci , vol.52 , pp. 521-527
    • Barnes, P.J.1
  • 2
    • 0025375882 scopus 로고
    • Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung
    • Mak JC, Barnes PJ. Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 1990; 141: 1559-68.
    • (1990) Am Rev Respir Dis , vol.141 , pp. 1559-1568
    • Mak, J.C.1    Barnes, P.J.2
  • 3
    • 0030442725 scopus 로고    scopus 로고
    • Muscarinic receptor subtypes and smooth muscle function
    • Eglen RM, Hegde SS, Watson N. Muscarinic receptor subtypes and smooth muscle function. Pharmacol Rev 1996; 48: 531-65.
    • (1996) Pharmacol Rev , vol.48 , pp. 531-565
    • Eglen, R.M.1    Hegde, S.S.2    Watson, N.3
  • 5
    • 0025191514 scopus 로고
    • Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle
    • Roffel AF, Elzinga CR, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990; 3: 47-51.
    • (1990) Pulm Pharmacol , vol.3 , pp. 47-51
    • Roffel, A.F.1    Elzinga, C.R.2    Zaagsma, J.3
  • 7
    • 0033534194 scopus 로고    scopus 로고
    • Tiotropium (Spiriva): Mechanistical considerations and clinical profile in obstructive lung disease
    • Disse B, Speck GA, Rominger KL, Witek TJ, Jr, Hammer R. Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease. Life Sci 1999; 64: 457-64.
    • (1999) Life Sci , vol.64 , pp. 457-464
    • Disse, B.1    Speck, G.A.2    Rominger, K.L.3    Witek Jr, T.J.4    Hammer, R.5
  • 8
    • 0028179195 scopus 로고
    • Characterization of {3H} 3Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: Radioligand binding and autoradiographic mapping
    • Haddad EB, Mak JC, Barnes PJ. Characterization of {3H} 3Ba 679 BR, a slowly dissociating muscarinic antagonist, in human lung: radioligand binding and autoradiographic mapping. Mol Pharmacol 1994; 45: 899-907.
    • (1994) Mol Pharmacol , vol.45 , pp. 899-907
    • Haddad, E.B.1    Mak, J.C.2    Barnes, P.J.3
  • 9
    • 0028886394 scopus 로고
    • Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: A pharmacodynamic study in patients with chronic obstructive pulmonary disease
    • Maessens FPV, Smeets JJ, Sledsens TJH, et al. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease. Eur Respir J 1995; 8: 1506-13.
    • (1995) Eur Respir J , vol.8 , pp. 1506-1513
    • Maessens, F.P.V.1    Smeets, J.J.2    Sledsens, T.J.H.3
  • 11
    • 0141990930 scopus 로고    scopus 로고
    • Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease
    • Calverly PM, Lee A, Towse L, et al. Effect of tiotropium bromide on circadian variation in airflow limitation in chronic obstructive pulmonary disease. Thorax 2003; 58: 855-60.
    • (2003) Thorax , vol.58 , pp. 855-860
    • Calverly, P.M.1    Lee, A.2    Towse, L.3
  • 12
    • 0037879081 scopus 로고    scopus 로고
    • Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses
    • Tashkin D, Kesten S. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses. Chest 2003; 123: 1441-9.
    • (2003) Chest , vol.123 , pp. 1441-1449
    • Tashkin, D.1    Kesten, S.2
  • 13
    • 37849014833 scopus 로고    scopus 로고
    • Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
    • Powrie DJ, Wilkinson TM, Donaldson GC, et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 2007; 30: 472-8.
    • (2007) Eur Respir J , vol.30 , pp. 472-478
    • Powrie, D.J.1    Wilkinson, T.M.2    Donaldson, G.C.3
  • 14
    • 34249338661 scopus 로고    scopus 로고
    • Acetylcholine-induced proliferation of fibroblast and myofibroblast in vitro is inhibited by tiotropium bromide
    • Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblast and myofibroblast in vitro is inhibited by tiotropium bromide. Life Sci 2007; 30: 2270-3.
    • (2007) Life Sci , vol.30 , pp. 2270-2273
    • Pieper, M.P.1    Chaudhary, N.I.2    Park, J.E.3
  • 15
    • 0030470881 scopus 로고    scopus 로고
    • New developments in anticholinergic drugs
    • Barnes P. New developments in anticholinergic drugs. Eur Respir Rev 1996; 6: 290-4.
    • (1996) Eur Respir Rev , vol.6 , pp. 290-294
    • Barnes, P.1
  • 16
    • 0024467177 scopus 로고
    • Cholinergic bronchomotor tone in COPD: Estimates of its amount in comparison to normal
    • Gross NJA, Skorodins MS. Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison to normal. Chest 1989; 96: 984-7.
    • (1989) Chest , vol.96 , pp. 984-987
    • Gross, N.J.A.1    Skorodins, M.S.2
  • 18
    • 77953397289 scopus 로고    scopus 로고
    • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines: workshop report. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated Setember, 2005. [Date last accessed: January 13, 2007]. Available from: http: //www.goldcop.com/ GuidelineList.asp?!1=2&!=1
    • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Guidelines: workshop report. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated Setember, 2005. [Date last accessed: January 13, 2007]. Available from: http: //www.goldcop.com/ GuidelineList.asp?!1=2&!=1
  • 19
    • 0035131180 scopus 로고    scopus 로고
    • The bronchodilator test with increasing doses of terbutaline in chonic obstructive pulmonary disease patients
    • Rodríguez-Carballeira M, Heredia JL, Rué M, Quintana S, Gómez L. The bronchodilator test with increasing doses of terbutaline in chonic obstructive pulmonary disease patients. Pulm Pharmacol Ther 2001; 14: 61-5.
    • (2001) Pulm Pharmacol Ther , vol.14 , pp. 61-65
    • Rodríguez-Carballeira, M.1    Heredia, J.L.2    Rué, M.3    Quintana, S.4    Gómez, L.5
  • 20
    • 0032928281 scopus 로고    scopus 로고
    • Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease
    • Rodríguez-Carballeira M, Heredia JL, Gómez L, Quintana S, Viñas C. Contribution of ipratropium bromide to the bronchodilator test in patients with chronic obstructive pulmonary disease. Pulm Pharmacol Ther 1999; 12: 43-8.
    • (1999) Pulm Pharmacol Ther , vol.12 , pp. 43-48
    • Rodríguez-Carballeira, M.1    Heredia, J.L.2    Gómez, L.3    Quintana, S.4    Viñas, C.5
  • 21
    • 33751516433 scopus 로고    scopus 로고
    • The bronchodilator test in chronic obstructive pulmonary disease: Interpretation methods
    • Rodríguez-Carballeira M, Heredia JL, Rué M, Quintana S, Almagro P. The bronchodilator test in chronic obstructive pulmonary disease: interpretation methods. Respir Med 2007: 101: 34-42.
    • (2007) Respir Med , vol.101 , pp. 34-42
    • Rodríguez-Carballeira, M.1    Heredia, J.L.2    Rué, M.3    Quintana, S.4    Almagro, P.5
  • 23
    • 0034099036 scopus 로고    scopus 로고
    • Long-acting bronchodilation with once-daily dosing of tiotropium (spiriva) in stable chronic obstructive pulmonary disease
    • Littner MR, Ilowite JS, Tashkin DP, et al. Long-acting bronchodilation with once-daily dosing of tiotropium (spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1136-42.
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 1136-1142
    • Littner, M.R.1    Ilowite, J.S.2    Tashkin, D.P.3
  • 24
    • 0036204964 scopus 로고    scopus 로고
    • Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease
    • Van Noord JA, Smeets JJ, Custers FL, et al. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 639-44.
    • (2002) Eur Respir J , vol.19 , pp. 639-644
    • Van Noord, J.A.1    Smeets, J.J.2    Custers, F.L.3
  • 25
    • 0036181956 scopus 로고    scopus 로고
    • A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease
    • Casaburi R, Mahler DA, Jones PW et al. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 217-24.
    • (2002) Eur Respir J , vol.19 , pp. 217-224
    • Casaburi, R.1    Mahler, D.A.2    Jones, P.W.3
  • 26
    • 18244368740 scopus 로고    scopus 로고
    • Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1year treatment with tiotropium
    • Vincken W, Van Noord JA, Greefhorst AP, et al. Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1year treatment with tiotropium. Eur Respir J 2002; 19: 209-16.
    • (2002) Eur Respir J , vol.19 , pp. 209-216
    • Vincken, W.1    Van Noord, J.A.2    Greefhorst, A.P.3
  • 27
    • 0036305399 scopus 로고    scopus 로고
    • A 6-month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol
    • Donohue JF, Van Noord JA, Bateman ED, et al. A 6-month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.
    • (2002) Chest , vol.122 , pp. 47-55
    • Donohue, J.F.1    Van Noord, J.A.2    Bateman, E.D.3
  • 28
    • 0038366897 scopus 로고    scopus 로고
    • Health outcomes following treatment for six months with once daily tiotropium compared twice daily salmeterol in patients with COPD
    • Brusasco V, Hodder R, Miravitlles M, et al. Health outcomes following treatment for six months with once daily tiotropium compared twice daily salmeterol in patients with COPD. Thorax 2003; 58: 399-404.
    • (2003) Thorax , vol.58 , pp. 399-404
    • Brusasco, V.1    Hodder, R.2    Miravitlles, M.3
  • 29
    • 53749102775 scopus 로고    scopus 로고
    • A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    • Tashkin DP, Celi B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543-54.
    • (2008) N Engl J Med , vol.359 , pp. 1543-1554
    • Tashkin, D.P.1    Celi, B.2    Senn, S.3
  • 30
    • 77953407864 scopus 로고    scopus 로고
    • Cazzola M, Santus P, D'Adda A, Pizzolato S, Di Marco F. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. Pulm Pharmacol Ther 2008. Web/URL PM: 19038356.
    • Cazzola M, Santus P, D'Adda A, Pizzolato S, Di Marco F. Acute effects of higher than standard doses of salbutamol and ipratropium on tiotropium-induced bronchodilation in patients with stable COPD. Pulm Pharmacol Ther 2008. Web/URL PM: 19038356.
  • 31
    • 33645116728 scopus 로고    scopus 로고
    • Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD
    • van Noord JA, Aumann Jl, Janssens E, et al. Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD. Chest 2006; 129: 509-17.
    • (2006) Chest , vol.129 , pp. 509-517
    • van Noord, J.A.1    Aumann, J.2    Janssens, E.3
  • 32
    • 34247561439 scopus 로고    scopus 로고
    • Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease
    • Aaron SD, Vandemheen KL, Fergusson D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease. Annals Int Med 2007; 146: 545-56.
    • (2007) Annals Int Med , vol.146 , pp. 545-556
    • Aaron, S.D.1    Vandemheen, K.L.2    Fergusson, D.3
  • 33
    • 0033925684 scopus 로고    scopus 로고
    • Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease
    • Taube C, Lehnigk B, Paasch K, et al. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 216-20.
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 216-220
    • Taube, C.1    Lehnigk, B.2    Paasch, K.3
  • 34
    • 0032778472 scopus 로고    scopus 로고
    • Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease
    • O'Donell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160: 542-9.
    • (1999) Am J Respir Crit Care Med , vol.160 , pp. 542-549
    • O'Donell, D.E.1    Lam, M.2    Webb, K.A.3
  • 35
    • 0034988166 scopus 로고    scopus 로고
    • Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease
    • Marin JM, Carrizo SJ, Gascon M, et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 63: 1395-9.
    • (2001) Am J Respir Crit Care Med , vol.63 , pp. 1395-1399
    • Marin, J.M.1    Carrizo, S.J.2    Gascon, M.3
  • 36
    • 0242721244 scopus 로고    scopus 로고
    • Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes
    • Celli B, Zu Wallack R, Wang S, et al. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes. Chest 2003; 24: 1743-8.
    • (2003) Chest , vol.24 , pp. 1743-1748
    • Celli, B.1    Zu Wallack, R.2    Wang, S.3
  • 37
    • 2542603339 scopus 로고    scopus 로고
    • Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD
    • O'Donnell DE, Flüge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832-40.
    • (2004) Eur Respir J , vol.23 , pp. 832-840
    • O'Donnell, D.E.1    Flüge, T.2    Gerken, F.3
  • 38
    • 77953433442 scopus 로고    scopus 로고
    • Gelb AF, Taylor CF, Cassino C, Shinar CM, Schein MJ, Zamel N. Pulm Pharmacol Ther 2009. Web/URL. PM: 19138754.
    • Gelb AF, Taylor CF, Cassino C, Shinar CM, Schein MJ, Zamel N. Pulm Pharmacol Ther 2009. Web/URL. PM: 19138754.
  • 39
    • 0021256105 scopus 로고
    • The measurement of dyspnea: Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
    • Mahler DA, Weinberg DH, Wells CK, et al. The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984; 85: 751-8.
    • (1984) Chest , vol.85 , pp. 751-758
    • Mahler, D.A.1    Weinberg, D.H.2    Wells, C.K.3
  • 40
    • 0034773257 scopus 로고    scopus 로고
    • Pulmonary Rehabilitation
    • British Thoracic Society Standards of Care Subcommittee on pulmonary Rehabilitation
    • British Thoracic Society Standards of Care Subcommittee on pulmonary Rehabilitation. Pulmonary Rehabilitation. Thorax 2001; 56: 827-34.
    • (2001) Thorax , vol.56 , pp. 827-834
  • 41
    • 0032937523 scopus 로고    scopus 로고
    • Pulmonary rehabilitation - 1999: Official statement of the American Thoracic Society
    • American Thoracic Society
    • American Thoracic Society. Pulmonary rehabilitation - 1999: official statement of the American Thoracic Society. Am J Respir Crit Care Med 1999; 159: 1666-82.
    • (1999) Am J Respir Crit Care Med , vol.159 , pp. 1666-1682
  • 42
    • 15844429415 scopus 로고    scopus 로고
    • Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD
    • Casaburi R, Kukafka D, Cooper CB, Witek TJ, Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005; 127: 809-17.
    • (2005) Chest , vol.127 , pp. 809-817
    • Casaburi, R.1    Kukafka, D.2    Cooper, C.B.3    Witek Jr, T.J.4    Kesten, S.5
  • 45
    • 37849011194 scopus 로고    scopus 로고
    • The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide
    • Wedzicha JA, Calverly MA, Seemungal TA, Hagan G, Ansari Z, Stockley RA. The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/ fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008; 177: 19-26.
    • (2008) Am J Respir Crit Care Med , vol.177 , pp. 19-26
    • Wedzicha, J.A.1    Calverly, M.A.2    Seemungal, T.A.3    Hagan, G.4    Ansari, Z.5    Stockley, R.A.6
  • 46
    • 34447570984 scopus 로고    scopus 로고
    • Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A systematic review with meta-analysis
    • Rodrigo GJ, Nannini LJ. Tiotropium for the treatment of stable chronic obstructive pulmonary disease: a systematic review with meta-analysis. Pulm Pharmacol Ther 2007; 20: 495-502.
    • (2007) Pulm Pharmacol Ther , vol.20 , pp. 495-502
    • Rodrigo, G.J.1    Nannini, L.J.2
  • 47
    • 33750029372 scopus 로고    scopus 로고
    • Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis
    • Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis. Thorax 2006; 61: 854-62.
    • (2006) Thorax , vol.61 , pp. 854-862
    • Barr, R.G.1    Bourbeau, J.2    Camargo, C.A.3    Ram, F.S.4
  • 48
  • 49
    • 48949103222 scopus 로고    scopus 로고
    • Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH study
    • Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332-8.
    • (2008) Am J Respir Crit Care Med , vol.178 , pp. 332-338
    • Celli, B.R.1    Thomas, N.E.2    Anderson, J.A.3
  • 50
    • 57349187989 scopus 로고    scopus 로고
    • Methodologic shortcomings of the INSPIRE randomized trial
    • Suissa S. Methodologic shortcomings of the INSPIRE randomized trial. Am J Respir Crit Care Med 2008: 178: 543-4.
    • (2008) Am J Respir Crit Care Med , vol.178 , pp. 543-544
    • Suissa, S.1
  • 51
    • 0037111198 scopus 로고    scopus 로고
    • Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: The COPE study
    • van der Valk P, Monninkhof E, van der Palen J, Zielhuis G, van Herwaarden C. Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study. Am J Respir Crit Care Med 2002; 166: 1358-63.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 1358-1363
    • van der Valk, P.1    Monninkhof, E.2    van der Palen, J.3    Zielhuis, G.4    van Herwaarden, C.5
  • 52
    • 48749129297 scopus 로고    scopus 로고
    • Survival with tiotropium compared to long-acting beta2-agonist in chronic obstructive pulmonary disease
    • Gershon AS, Wang L, To T, Luo J, Upshur RE. Survival with tiotropium compared to long-acting beta2-agonist in chronic obstructive pulmonary disease. COPD 2008; 5: 229-34.
    • (2008) COPD , vol.5 , pp. 229-234
    • Gershon, A.S.1    Wang, L.2    To, T.3    Luo, J.4    Upshur, R.E.5
  • 53
    • 0027962628 scopus 로고
    • Effects of smoking intervention and the use of an inhales anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study
    • Anthonissen NR, Connet JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhales anticholinergic bronchodilator on the rate of decline of FEV1: the Lung Health Study. JAMA 1994; 272: 1497-1505.
    • (1994) JAMA , vol.272 , pp. 1497-1505
    • Anthonissen, N.R.1    Connet, J.E.2    Kiley, J.P.3
  • 54
    • 11844265905 scopus 로고    scopus 로고
    • One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium
    • Anzueto A, Tashkin D, Menjoge S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulm Pharmacol Ther 2005; 18: 75-81.
    • (2005) Pulm Pharmacol Ther , vol.18 , pp. 75-81
    • Anzueto, A.1    Tashkin, D.2    Menjoge, S.3
  • 55
    • 0034727828 scopus 로고    scopus 로고
    • Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
    • The Lung Health Study Research Group
    • The Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 1902-9.
    • (2000) N Engl J Med , vol.343 , pp. 1902-1909
  • 56
    • 0345188819 scopus 로고    scopus 로고
    • Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking
    • Paweles RA, Löfdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 1999; 340: 1948-53.
    • (1999) N Engl J Med , vol.340 , pp. 1948-1953
    • Paweles, R.A.1    Löfdahl, C.G.2    Laitinen, L.A.3
  • 57
    • 0034643610 scopus 로고    scopus 로고
    • Randomised, double blind placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
    • Burge PS, Calverly PM, Jones PW, Spencer S, Anderson JA, Maslen TK. Randomised, double blind placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320: 1297-303.
    • (2000) BMJ , vol.320 , pp. 1297-1303
    • Burge, P.S.1    Calverly, P.M.2    Jones, P.W.3    Spencer, S.4    Anderson, J.A.5    Maslen, T.K.6
  • 58
    • 20944433417 scopus 로고    scopus 로고
    • Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005; 365: 1552-60. (Erratum, Lancet 2005; 366: 984).
    • Decramer M, Rutten-van Mölken M, Dekhuijzen PN, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet 2005; 365: 1552-60. (Erratum, Lancet 2005; 366: 984).
  • 59
    • 33845938174 scopus 로고    scopus 로고
    • Pooled clinical trial analysis of tiotropium safety
    • Kesten S, Jara M, Wentworth C, Lanes S. Pooled clinical trial analysis of tiotropium safety. Chest 2006; 130: 1695- 1703.
    • (2006) Chest , vol.130 , pp. 1695-1703
    • Kesten, S.1    Jara, M.2    Wentworth, C.3    Lanes, S.4
  • 60
    • 52449106502 scopus 로고    scopus 로고
    • Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
    • Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300: 1439-50.
    • (2008) JAMA , vol.300 , pp. 1439-1450
    • Singh, S.1    Loke, Y.K.2    Furberg, C.D.3
  • 62
    • 34248382008 scopus 로고    scopus 로고
    • Cardiovascular an respiratory hospitalizations and mortality among users of tiotropium in Denmark
    • de Luise C, Lanes SF, Jacobsen J, Pedersen L, Sorensen HT. Cardiovascular an respiratory hospitalizations and mortality among users of tiotropium in Denmark. Eur J Epidemiol 2007; 22: 267-72.
    • (2007) Eur J Epidemiol , vol.22 , pp. 267-272
    • de Luise, C.1    Lanes, S.F.2    Jacobsen, J.3    Pedersen, L.4    Sorensen, H.T.5
  • 63
    • 0029993821 scopus 로고    scopus 로고
    • Prolonged effect of tiotropium bromide on metacholine-induced bronchoconstriction in asthma
    • O'Connor BJ, Towse LJ, Barnes PJ. Prolonged effect of tiotropium bromide on metacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 1996; 154: 876-80.
    • (1996) Am J Respir Crit Care Med , vol.154 , pp. 876-880
    • O'Connor, B.J.1    Towse, L.J.2    Barnes, P.J.3
  • 64
    • 34247645201 scopus 로고    scopus 로고
    • A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma
    • Fardon T, Haggart K, Lee DK, Lipworth BJ. A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. Respir Med 2007; 101: 1218-28.
    • (2007) Respir Med , vol.101 , pp. 1218-1228
    • Fardon, T.1    Haggart, K.2    Lee, D.K.3    Lipworth, B.J.4
  • 65
    • 33646556210 scopus 로고    scopus 로고
    • Anticholinergic agents in asthma: Chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling
    • Kanazawa H. Anticholinergic agents in asthma: chronic bronchodilator therapy, relief of acute severe asthma, reduction of chronic viral inflammation and prevention of airway remodeling. Curr Opin Pulm Med 2006; 12: 60-7.
    • (2006) Curr Opin Pulm Med , vol.12 , pp. 60-67
    • Kanazawa, H.1
  • 67
    • 49649102385 scopus 로고    scopus 로고
    • Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype
    • Iwamoto H, Yokoyama A, Shiota N, et al. Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype. Eur Respir J 2008; 31: 1379-82.
    • (2008) Eur Respir J , vol.31 , pp. 1379-1382
    • Iwamoto, H.1    Yokoyama, A.2    Shiota, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.